Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma × Protons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Meningioma 2 HER2-positive Breast Cancer 2 Glioma 2 Glioblastoma 2 Chordoma 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Radiation Injuries 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lung Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1

Interventions

Doxorubicin 57 Radiotherapy 40 Ifosfamide 39 Gemcitabine 37 Cyclophosphamide 29 Docetaxel 24 pazopanib 23 Filgrastim 22 pembrolizumab 21 Nivolumab 20 Trabectedin 19 Etoposide 18 Cisplatin 17 Surgical Procedures, Operative 16 Blood Specimen Collection 15 Radiation 12 Carboplatin 12 liposomal doxorubicin 11 Ipilimumab 11 apatinib 10 anlotinib 10 Vincristine 10 Radiosurgery 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Magnetic Resonance Spectroscopy 10 Drug Therapy 10 Bevacizumab 10 Temozolomide 9 Sorafenib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04946357 2026-03-10

EXTREM ION

University Hospital Heidelberg

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡